Christina Kinch
Chief Corporate Communications Officer
Replay available
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Q4 2025 earnings conference call, held 2026-02-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Yvonne Greenstreet
Chief Executive Officer
Tolga Tangular
Chief Commercial Officer
Pushkal Garg
Chief Research and Development Officer
Jeff Fulton
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Alnylam Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.031 Thank 00:00:25.672 -- 00:00:27.672 you. 00:00:33.950 -- 00:00:35.950 Thank 00:00:50.343 -- 00:00:52.343 you. 00:01:17.082 -- 00:01:19.082 Thank 00:01:37.711 -- 00:01:39.711 you. 00:01:42.142 -- 00:01:44.142 Thank 00:02:09.824 -- 00:02:11.824 you. 00:02:12.854 -- 00:02:14.356 Thank 00:02:14.356 -- 00:02:16.356 you. 00:02:22.948 -- 00:02:24.948 Thank 00:02:40.672 -- 00:02:42.672 you. 00:02:59.159 -- 00:03:01.159 Thank 00:03:16.740 -- 00:03:18.740 you. 00:03:37.212 -- 00:03:39.212 Thank 00:03:58.111 -- 00:03:59.639 you. 00:03:59.639 -- 00:04:01.639 Thank 00:04:28.807 -- 00:04:30.807 you. 00:04:57.790 -- 00:04:59.790 Thank 00:05:26.418 -- 00:05:28.418 you. 00:05:28.925 -- 00:05:30.925 Thank 00:05:31.109 -- 00:05:33.109 you. 00:05:35.556 -- 00:05:37.556 Thank 00:05:50.262 -- 00:05:52.262 you. 00:06:17.322 -- 00:06:19.322 Thank 00:06:46.658 -- 00:06:48.658 you. 00:06:54.127 -- 00:06:56.127 Thank 00:06:59.972 -- 00:07:01.972 you. 00:07:36.027 -- 00:07:37.449 Thank 00:07:37.449 -- 00:07:40.511 you. Thank 00:08:01.027 -- 00:08:03.027 you. 00:08:04.597 -- 00:08:06.597 Thank 00:08:22.423 -- 00:08:24.423 you. 00:08:37.621 -- 00:08:39.621 Thank 00:08:57.001 -- 00:08:59.001 you. 00:08:59.457 -- 00:09:01.457 ¶¶ 00:09:57.946 -- 00:09:59.946 Thank 00:10:24.413 -- 00:10:26.413 you. 00:10:29.063 -- 00:10:31.063 Thank 00:10:49.979 -- 00:10:51.979 you. 00:11:00.113 -- 00:11:05.160 Good morning, ladies and gentlemen, and welcome to the Nilem Pharmaceuticals 00:11:05.160 -- 00:11:09.867 Q4 and full year 2025 earnings conference call. 00:11:09.867 -- 00:11:13.091 At this time, all lines are in listen-only mode. 00:11:13.091 -- 00:11:16.857 Following the presentation, we will conduct a question and answer session. 00:11:16.857 -- 00:11:21.944 If at any tim...